Jiangsu Hengrui Medicine
600276.SS
#460
Rank
ยฃ33.05 B
Marketcap
ยฃ5.18
Share price
-1.68%
Change (1 day)
7.08%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): ยฃ0.07546

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is ยฃ0.06828. In 2022 the company made an earnings per share (EPS) of ยฃ0.06809 a decrease over its 2021 EPS that were of ยฃ0.08213.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ0.0754610.83%
2022ยฃ0.06809-17.1%
2021ยฃ0.08213-24.44%
2020ยฃ0.1120.3%
2019ยฃ0.0903525.58%
2018ยฃ0.0719527.55%
2017ยฃ0.0564121.64%
2016ยฃ0.0463713.57%
2015ยฃ0.0408339.86%
2014ยฃ0.0291921.33%
2013ยฃ0.0240617.7%
2012ยฃ0.0204425.56%
2011ยฃ0.0162826.22%
2010ยฃ0.0129010.3%
2009ยฃ0.0116957.92%
2008ยฃ0.00740511.06%
2007ยฃ0.00666885.81%
2006ยฃ0.00358887.94%
2005ยฃ0.00190933.97%
2004ยฃ0.00142529.78%
2003ยฃ0.00109819.78%
2002ยฃ0.0009167